Patent details

EP1210951 Title: Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone

Basic Information

Publication number:
EP1210951
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP013094578
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone
French Title of Invention:
Composition contenant des agoniste-antagonistes d'oestrogène et de la testostérone pour le traitement d' une réduction des taux de l'hormone testostérone
German Title of Invention:
Östrogen Agonist-Antagonist und Testosteron enthaltende Zusammensetzung zur Behandlung abnehmender Testosteronspiegel
SPC Number:

Dates

Filing date:
08/11/2001
Grant date:
02/02/2005
EP Publication Date:
02/02/2005
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/06/2002
EP B1 Publication Date:
02/02/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/11/2006
Expiration date:
08/11/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/11/2001
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
02/02/2005
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
McLean David Burton, c/o Pfizer Global Res.& Dev.
Address:
United States (US)

Priority

Priority Number:
250071 P
Priority Date:
30/11/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61P 3/06;
Filing date Document type Number of pages